Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 1296-1299, April 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oredsson, S. M.
Right arrow Articles by Marton, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oredsson, S. M.
Right arrow Articles by Marton, L. J.

Decreased Cytotoxicity of cis-Diamminedichloroplatinum(II) by {alpha}-Difluoromethylornithine Depletion of Polyamines in 9L Rat Brain Tumor Cells in Vitro1

Stina M. Oredsson2, Dennis F. Deen and Laurence J. Marton3

Brain Tumor Research Center of the Department of Neurological Surgery [S. M. O., D. F. D., L. J. M.] and Departments of Radiation Oncology [D. F. D.] and Laboratory Medicine [L. J. M.], School of Medicine, University of California, San Francisco, California 94143

Before treatment with the cytotoxic drug cis-dichlorodiammineplatinum(II) (cis-platinum), 9L rat brain gliosarcoma cells grown in vitro were depleted of intracellular polyamines by {alpha}-difluoromethylornithine (DFMO; 10 mM, 48 hr), an enzymeactivated, irreversible inhibitor of the polyamine-synthetic enzyme ornithine decarboxylase. In contrast to studies that showed that the cytotoxicity of 1,3-bis (2-chloroethyl)-1-nitrosourea as measured by colony-forming efficiency is enhanced by DFMO depletion of intracellular polyamines, the cytotoxicity of cis-platinum was significantly decreased in polyamine-depleted 9L cells. At 10, 1, and 0.1% survival levels, the dose modification factors were 2.0 to 2.1. Addition of exogenous putrescine to polyamine-depleted 9L cells 24 hr before treatment with cis-platinum partially reversed this phenomenon. When 9L cells were treated either with DFMO and cis-platinum or with DFMO, putrescine, and cis-platinum for 1 hr, a time period that is too short for DFMO to affect intracellular polyamine levels, the cytotoxicity of cis-platinum was decreased, but to a significantly lesser extent than by the 48-hr DFMO pretreatment. Putrescine alone did not alter the cytotoxic effect of cis-platinum when administered either 24 or 1 hr before treatment. DFMO appears to affect cis-platinum cytotoxicity by two different mechanisms, the first medicated through polyamine depletion and the second through a direct interaction with cis-platinum.

1 Supported by American Cancer Society Grant RD-137, NIH Grant CA-13525 and the Morris Stulsaft Foundation.

2 Recipient of travel grants from the Swedish Natural Science Research Council (R-RA 4685-100) and the Swedish Medical Research Council (B 81-04R-6065-504106065). Visiting predoctoral fellow at the Brain Tumor Research Center.

3 To whom requests for reprints should be addressed, at Brain Tumor Research Center, 783 HSW, University of California, San Francisco, Calif., 94143.

Received 11/ 2/81. Accepted 1/13/82.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. M. Fischer, M. Lee, and R. A. Lubet
Difluoromethylornithine is effective as both a preventive and therapeutic agent against the development of UV carcinogenesis in SKH hairless mice
Carcinogenesis, January 1, 2001; 22(1): 83 - 88.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. L. Meyskens Jr. and E. W. Gerner
Development of Difluoromethylornithine (DFMO) as a Chemoprevention Agent
Clin. Cancer Res., May 1, 1999; 5(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Tofilon, D. Deen, and L. Marton
Polyamine depletion and drug-induced chromosomal damage: new results
Science, November 20, 1992; 258(5086): 1378 - 1378.
[PDF]


Home page
ScienceHome page
P. Tofilon, D. Deen, and L. Marton
alpha-Difluoromethylornithine-induced polyamine depletion of 9L tumor cells modifies drug-induced DNA cross-link formation
Science, December 9, 1983; 222(4628): 1132 - 1135.
[Abstract] [PDF]


Home page
ScienceHome page
D. Hung, L. Marton, D. Deen, and R. Shafer
Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells
Science, July 22, 1983; 221(4608): 368 - 370.
[Abstract] [PDF]


Home page
ScienceHome page
P. Tofilon, S. Oredsson, D. Deen, and L. Marton
Polyamine depletion influences drug-induced chromosomal damage
Science, September 10, 1982; 217(4564): 1044 - 1046.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.